To whom do the research findings apply?
作者信息
Furberg Curt D
机构信息
Department of Public Health Sciences, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1063, USA.
出版信息
Heart. 2002 Jun;87(6):570-4. doi: 10.1136/heart.87.6.570.
Abstract
摘要
相似文献
1
To whom do the research findings apply?这些研究结果适用于谁？
Heart. 2002 Jun;87(6):570-4. doi: 10.1136/heart.87.6.570.
2
Ethical aspects of pediatric therapeutic clinical trials.
Acta Gastroenterol Belg. 1998 Apr-Jun;61(2):243-4.
3
Ethics of randomised clinical trials.随机临床试验的伦理学
J Med Ethics. 1980 Jun;6(2):55-7. doi: 10.1136/jme.6.2.55.
4
Monitoring for adherence: ethical considerations.监测依从性：伦理考量
Am J Respir Crit Care Med. 1994 Feb;149(2 Pt 1):287-8. doi: 10.1164/ajrccm.149.2.8306018.
5
Philosophy on trial: examining ethics of clinical investigations.受审的哲学：审视临床研究的伦理问题
JAMA. 1988 Aug 12;260(6):749-51.
6
Paternalism no problem.家长作风没问题。
Hastings Cent Rep. 1992 Mar-Apr;22(2):4-5.
7
Research ethics and clinical trials: fostering collaboration with research participants.研究伦理与临床试验：促进与研究参与者的合作
Account Res. 1999;6(3):215-26. doi: 10.1080/08989629908573929.
8
Research ethics.研究伦理。
West Indian Med J. 1995 Dec;44(4):115-8.
9
Ethics and preventive medicine: the case of borderline hypertension.伦理学与预防医学：临界高血压病例
Hastings Cent Rep. 1981 Feb;11(1):12-20.
10
Informed consent and randomised controlled trials.
J R Coll Surg Edinb. 2001 Apr;46(2):100-2.
引用本文的文献
1
The mechanistic rationale of drugs, primary endpoints, geographical distribution of clinical trials against severe acute respiratory syndrome-related coronavirus-2: A systematic review.药物的作用机制、主要终点、针对严重急性呼吸综合征相关冠状病毒-2 的临床试验的地理分布：系统评价。
J Med Virol. 2021 Feb;93(2):843-853. doi: 10.1002/jmv.26338. Epub 2020 Aug 2.
2
Are elderly and women under-represented in cardiovascular clinical trials? Implication for treatment.心血管临床试验中老年人和女性的代表性不足吗？对治疗的影响。
Wien Klin Wochenschr. 2016 Dec;128(Suppl 7):433-438. doi: 10.1007/s00508-016-1082-x. Epub 2016 Sep 21.
3
The winged chariot and the iron cages.带翼的战车和铁笼。
Ulster Med J. 2006 Sep;75(3):178-84.
本文引用的文献
1
Clinical Implications of Recent Findings from the Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial (ALLHAT) and Other Studies of Hypertension.降压和降脂治疗预防心脏病发作试验（ALLHAT）及其他高血压研究近期结果的临床意义
Ann Intern Med. 2001 Dec 18;135(12):1074-8. doi: 10.7326/0003-4819-135-12-200112180-00011.
2
Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial.吉非贝齐治疗及血脂水平与主要冠状动脉事件的关系：退伍军人事务部高密度脂蛋白胆固醇干预试验（VA-HIT）：一项随机对照试验。
JAMA. 2001 Mar 28;285(12):1585-91. doi: 10.1001/jama.285.12.1585.
3
Underrepresentation of patients 65 years of age or older in cancer-treatment trials.65岁及以上患者在癌症治疗试验中的代表性不足。
N Engl J Med. 1999 Dec 30;341(27):2061-7. doi: 10.1056/NEJM199912303412706.
4
Incommunicable knowledge? Interpreting and applying the results of clinical trials and meta-analyses.不可言传的知识？解读与应用临床试验及荟萃分析的结果。
J Clin Epidemiol. 1998 Apr;51(4):289-95. doi: 10.1016/s0895-4356(97)00293-x.
5
Valvular heart disease associated with fenfluramine-phentermine.与芬氟拉明-苯丙胺相关的心脏瓣膜病。
N Engl J Med. 1997 Aug 28;337(9):581-8. doi: 10.1056/NEJM199708283370901.
6
Underrepresentation of women in clinical drug trials.女性在临床药物试验中的代表性不足。
Clin Pharmacol Ther. 1993 Jul;54(1):11-5. doi: 10.1038/clpt.1993.102.
7
Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project.冠状动脉药物项目中治疗依从性和胆固醇反应对死亡率的影响。
N Engl J Med. 1980 Oct 30;303(18):1038-41. doi: 10.1056/NEJM198010303031804.
8
9
Mortality in non-consenters in a post-myocardial infarction trial.心肌梗死后试验中未同意参与者的死亡率。
J Intern Med. 1990 Sep;228(3):253-6. doi: 10.1111/j.1365-2796.1990.tb00227.x.
10
The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience.
Ann Intern Med. 1990 Feb 15;112(4):293-9. doi: 10.7326/0003-4819-112-4-293.
Zotero 插件